Useful information

Again, his brother's stem cells saved life


Similar to the first intervention, the Krio Institute, Hungary's market-leading stem cell bank, provided a deep frozen, minus 190 degree Celsius sample.


Secondly, stem cells stored in a private stem cell bank were successfully implanted in Hungary. Similar to the first transplant, the two-year-old baby fell in a successful intervention in Miskolc. Krio Institute, a market-leading stem cell bank in Hungary that has stored inoculated stem cells, has begun a worldwide patented freezing procedure test that can further improve the efficiency of freezing freezing.
One year after the first successful stem cell transplantation, which was secured by a private stem cell bank, another successful transplantation was carried out in Miskolc. The baby, two years old, suffered from a deficiency of blood platelets, which was accompanied by other haemorrhagic organ disorders 10 months ago. The disease developed into acute leukemia at 13 months. The standard treatment did not work, so the child's doctor decided to implant the stem cells that were removed and retained at birth.
Professionally harvested and stored conditions, stem cells are capable of restoring the bone marrow of sick children and of restoring new bone marrow. Stem cells contain healthy cells in the sick child's body - bone marrow and through this blood - that do not have malignant lesions, so these cells give rise to a potential for healing. The couple's implantation was successful a month ago, and the baby's healthy blood count has begun thanks to donor stem cells.
Currently, in Hungary, it is primarily used to cure patients with cancer of the carcinoma, which can also be used to cure countless other diseases. Stem cells are also capable of "re-inventing" whole organs based on international research results.
In order to make the cells harvested at birth more suitable for use in the supernatant, stem cell banks are constantly developing the applied freezing technology. Recently, the Krio Institute has begun testing a new freezing procedure from the European Union to support a domestic global patent and provide a unique opportunity to freeze. The essence of technology is that special cells are "trenched" by deep freezing, which is much more likely to produce a "shock" of cooling, thereby improving the health of the cells as quickly as possible.